We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
326
Penobscot Investment Management
Massachusetts
$250K – – –
WWM
327
Western Wealth Management
Colorado
$244K -$138 -1 -0.1%
BCM
328
BlueCrest Capital Management
Jersey
$244K +$237K +1,720 New
TRCT
329
Tower Research Capital (TRC)
New York
$237K -$105K -762 -31%
SAM
330
Symphony Asset Management
California
$236K -$16.1K -117 -7%
AP
331
Advisor Partners
California
$235K +$228K +1,659 New
BFS
332
Bradley Foster & Sargent
Connecticut
$230K – – –
VF
333
Virtu Financial
New York
$223K +$216K +1,569 New
GWM
334
Geneos Wealth Management
Colorado
$222K – – –
CCIA
335
Campbell & Co Investment Adviser
Maryland
$222K +$215K +1,565 New
GIA
336
Guyasuta Investment Advisors
Pennsylvania
$212K +$205K +1,492 New
QI
337
Qtron Investments
Massachusetts
$209K +$203K +1,473 New
Simplex Trading
338
Simplex Trading
Illinois
$200K -$122K -887 -39%
DT
339
Diversified Trust
Tennessee
$200K +$194K +1,412 New
EIP
340
Ellis Investment Partners
Pennsylvania
$197K – – –
PAM
341
Panagora Asset Management
Massachusetts
$185K – – –
Toronto Dominion Bank
342
Toronto Dominion Bank
Ontario, Canada
$183K +$178K +1,290 New
CAPTRUST Financial Advisors
343
CAPTRUST Financial Advisors
North Carolina
$169K -$20.8K -151 -11%
CFGS
344
Concourse Financial Group Securities
Alabama
$162K +$122K +884 +345%
CIM
345
Contravisory Investment Management
Massachusetts
$156K – – –
HAG
346
HighPoint Advisor Group
Illinois
$129K -$22.3K -162 -16%
GC
347
Globeflex Capital
California
$122K +$119K +861 New
Fidelity Investments
348
Fidelity Investments
Massachusetts
$121K -$3.72K -27 -3%
APA
349
American Portfolios Advisors
New York
$121K +$66.1K +480 +129%
PFBT
350
Parkside Financial Bank & Trust
Missouri
$120K -$1.51K -11 -1%
12 13
14
15 16

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.